Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.
Saved in:
| Title: | Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial. |
|---|---|
| Authors: | Finkel RS; St. Jude Children's Research Hospital, Memphis, TN, USA. richard.finkel@stjude.org., Crawford TO; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Mercuri E; Centro clinico NeMO, Fondazione A. Policlinico Gemelli IRCCS, Rome, Italy.; Pediatric Neurology Unit, Catholic University, Rome, Italy., Sumner CJ; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Garcia Romero MDM; Hospital La Paz, Madrid, Spain., Day JW; Stanford University School of Medicine, Stanford, CA, USA., Montes J; Columbia University Irving Medical Center, New York, NY, USA., Sun P; Biogen, Cambridge, MA, USA., Tichler B; Biogen, Zug, Switzerland., Paradis AD; Biogen, Cambridge, MA, USA., Boesch E; Biogen, Cambridge, MA, USA., Inra J; Biogen, Cambridge, MA, USA., Littauer R; Biogen, Cambridge, MA, USA., Sohn J; Biogen, Cambridge, MA, USA., Monine M; Biogen, Cambridge, MA, USA., Gambino G; Biogen, Maidenhead, UK., Foster R; Biogen, Maidenhead, UK., Farewell R; Biogen, Cambridge, MA, USA., Fradette S; Biogen, Cambridge, MA, USA. stephanie.fradette@biogen.com. |
| Source: | Nature medicine [Nat Med] 2026 May; Vol. 32 (5), pp. 1936. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
